USFDA approves Sanofi Qfitlia for hemophilia A or B with or without inhibitors Ruchika Sharma29 March 2025 11:30 AM ISTParis: Sanofi has announced that the Company has received approval from the US Food and Drug Administration (FDA) for Qfitlia...
Sanofi gets USFDA fast track designation for Chlamydia vaccine candidate Ruchika Sharma27 March 2025 3:22 PM ISTParis: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate for the...
Sanofi Tolebrutinib under USFDA priority review for multiple sclerosis Ruchika Sharma25 March 2025 12:15 PM ISTTolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory authority.
Sanofi to buy Autoimmune Disease treatment from Dren Bio for up to USD 1.9 billion Ruchika Sharma20 March 2025 11:30 AM ISTParis: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi...
Sanofi Sarclisa combo gets Japanese nod for newly diagnosed multiple myeloma Ruchika Sharma27 Feb 2025 11:30 AM ISTParis: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with...
USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid Ruchika Sharma20 Feb 2025 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license...
Sanofi acquires 2.3% of its shares from long-standing shareholder L'Oréal Ruchika Sharma4 Feb 2025 1:06 PM ISTParis: Sanofi has announced the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s...
Sanofi Sarclisa approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Ruchika Sharma2 Feb 2025 10:45 AM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a...
Sanofi Sarclisa approved in EU for newly diagnosed multiple myeloma Ruchika Sharma26 Jan 2025 1:30 PM ISTParis: Following the adoption of a positive opinion by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
Sanofi Sarclisa gains Chinese nod for treatment of adult patients with relapsed or refractory multiple myeloma Ruchika Sharma14 Jan 2025 1:30 PM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, an anti-CD38 medicine,...
Sanofi appoints Jean-Paul Kress as Independent Director Ruchika Sharma21 Dec 2024 12:30 PM ISTParis: Sanofi has announced the appointment of Jean-Paul Kress as an Independent Director, effective January 1, 2025. Jean-Paul Kress will...
Sanofi gets USFDA Breakthrough Therapy designation for multiple sclerosis therapy Tolebrutinib Ruchika Sharma17 Dec 2024 11:32 AM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Tolebrutinib for the...
